Cargando…
Immunotherapy for the Treatment of Breast Cancer: Emerging New Data
Breast cancer is the most common type of cancer affecting women in the United States. Triple-negative breast cancer remains the most aggressive molecular subtype secondary to a lack of therapeutic targets. The search for a target has led us to investigate immunotherapeutic agents. Immunotherapy has...
Autores principales: | Mina, Lida A, Lim, Shannon, Bahadur, Shakeela W, Firoz, Abdul T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997226/ https://www.ncbi.nlm.nih.gov/pubmed/32099454 http://dx.doi.org/10.2147/BCTT.S184710 |
Ejemplares similares
-
Emerging nanomedicines for effective breast cancer immunotherapy
por: Bahreyni, Amirhossein, et al.
Publicado: (2020) -
New Immunotherapy Strategies in Breast Cancer
por: Yu, Lin-Yu, et al.
Publicado: (2017) -
Immunotherapy for Breast Cancer Treatment
por: Simonian, Miganoosh, et al.
Publicado: (2021) -
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
por: Sánchez-León, María Luisa, et al.
Publicado: (2023) -
New emerging targets in cancer immunotherapy: the role of VISTA
por: Tagliamento, Marco, et al.
Publicado: (2020)